In this study, we found that increased PERK expression correlates with poor prognosis and increased immune infiltration levels in B cells, CD8+ T cells, macrophages, neutrophils, and dendritic cells of multiple cancers, especially in breast and thyroid cancers. This evidence concerns the gene EIF2AK3 and thyroid cancer.